ABBVIE INC. vs. Arcus Biosciences, Inc.
ABBVIE INC. and Arcus Biosciences, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | RCUS | |
|---|---|---|
| Market Cap | $510.84 billion | $3.02 billion |
ABBV leads on 1 of 1 size & scale factors.
Dividend
| ABBV | RCUS | |
|---|---|---|
| Dividend Yield | 2.43% | — |
ABBV and RCUS split the dividend factors evenly.
Risk & Sentiment
| ABBV | RCUS | |
|---|---|---|
| Short Interest | 0.85% | 0.06% |
RCUS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, RCUS overview, RCUS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
